Open $41.82
Day Range 41.58 - 42.20
52 Week Range 32.78 - 43.08
Market Cap $234.04B
Shares Outstanding 5.6B
Public Float 5.6B
Beta 0.68
Rev. per Employee $533.86K
P/E Ratio 21.42
EPS $1.97
Yield 3.71%
Dividend $0.39
Ex-Dividend Date Jul 29, 2021
Short Interest 61.24M 07/15/21
% of Float Shorted 1.09%
Average Volume 24.8M

5 Day	2.63%
1 Month	7.51%
3 Month	8.48%
YTD	14.37%
1 Year	13.20%

Sell
Under
Hold
Over
Buy

Number of Ratings 21 Full Ratings

MarketWatch
Dow Jones

Pfizer's COVID-19 vaccine generated $7.8 billion in revenue in the second quarter

Jul. 28, 2021 at 8:43 a.m. ET by Jaimy Lee

Barron's

Pfizer Says It Will Now Sell $33.5 Billion of Its Covid-19 Vaccine This Year

Jul. 28, 2021 at 8:38 a.m. ET by Barron's

Pfizer shares limited data about its COVID-19 booster candidate, says it ups protection against the delta variant

Jul. 28, 2021 at 8:01 a.m. ET by Jaimy Lee

CDC: Vaccinated Americans should start wearing masks again indoors in areas with high COVID-19 transmission rates

Jul. 27, 2021 at 3:18 p.m. ET by Jaimy Lee

Pfizer says 2.1 bln doses of COVID vaccine are due to be delivered in 2021

Jul. 28, 2021 at 7:00 a.m. ET by Ciara Linnane

Pfizer now sees full-year revenue of about $33.5 bln from COVID-19 vaccine

Jul. 28, 2021 at 6:55 a.m. ET by Ciara Linnane

Pfizer says COVID-19 vaccine contributed $7.8 bln in direct sales and alliance revenues

Jul. 28, 2021 at 6:53 a.m. ET by Ciara Linnane

Pfizer previous guidance was for adj. EPS of $3.55 to $3.65; revenue of $70.5 bln to $72.5 bln

Jul. 28, 2021 at 6:52 a.m. ET by Ciara Linnane

Pfizer shares up 0.7% premarket

Jul. 28, 2021 at 6:50 a.m. ET by Ciara Linnane

Pfizer now sees full-year adj. EPS of $3.95 to $4.05

Jul. 28, 2021 at 6:50 a.m. ET by Ciara Linnane

Pfizer raises full-year guidance, now sees revenue of $78.0 bln to $80.0 bln

Jul. 28, 2021 at 6:50 a.m. ET by Ciara Linnane

Pfizer says it has delivered more than 1 bln doses of its COVID-19 vaccine globally

Jul. 28, 2021 at 6:49 a.m. ET by Ciara Linnane

Pfizer Q2 revenue $18.977 bln vs. $9.864 bln a year ago; FactSet consensus $18.706 bln

Jul. 28, 2021 at 6:49 a.m. ET by Ciara Linnane

Pfizer Q2 adj. EPS $1.07; FactSet consensus 97 cents

Jul. 28, 2021 at 6:48 a.m. ET by Ciara Linnane

Pfizer Q2 EPS 98 cents vs. 62 cents a year ago

Jul. 28, 2021 at 6:48 a.m. ET by Ciara Linnane

CDC reverses policy on face masks, amid reports of breakthrough infections with delta variant of COVID-19

Jul. 27, 2021 at 11:24 a.m. ET by Ciara Linnane

Barron's

CDC Recommends That Vaccinated People Resume Wearing Masks Indoors

Jul. 27, 2021 at 11:21 a.m. ET

Pfizer Inc. stock outperforms competitors on strong trading day

Jul. 27, 2021 at 5:15 p.m. ET by MarketWatch Automation

Barron's

Covid Cases Are Dropping in the U.K. What It Means for the U.S.

Jul. 27, 2021 at 8:50 a.m. ET by Barron's

Barron's

Why It’s Hard to Go Wrong With Bristol Myers Stock

Jul. 27, 2021 at 6:00 a.m. ET by Barron's

No Headlines Available

Other News
Press Releases

Here's What the Surge in COVID's Delta Variant Could Mean for Pfizer's Stock

Jul. 28, 2021 at 8:39 a.m. ET on Motley Fool

Pfizer (PFE) Receives a Hold from Mizuho Securities

Jul. 28, 2021 at 8:25 a.m. ET on TipRanks.com

3 Top Robinhood Stocks That Shrewd Investors Should Buy Right Now

Jul. 28, 2021 at 8:11 a.m. ET on Motley Fool

Is Moderna a Warren Buffett Stock?

Jul. 28, 2021 at 7:51 a.m. ET on Motley Fool

3 Things That Will Make or Break Novavax's Earnings Report Next Week

Jul. 28, 2021 at 6:00 a.m. ET on Motley Fool

3 Big Hints That COVID Vaccine Booster Doses Are on the Way

Jul. 28, 2021 at 5:52 a.m. ET on Motley Fool

Why Novavax Stock Is Sliding Today

Jul. 27, 2021 at 11:42 a.m. ET on Motley Fool

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

Jul. 27, 2021 at 8:50 a.m. ET on 247WallSt.com

200 Million More Reasons to Buy Pfizer Stock

Jul. 27, 2021 at 5:52 a.m. ET on Motley Fool

Why Moderna Stock Slipped Today

Jul. 26, 2021 at 4:41 p.m. ET on Motley Fool

Earnings Previews: Boeing, McDonald’s, Pfizer, Tilray

Jul. 26, 2021 at 12:50 p.m. ET on 247WallSt.com

Here's Why the Bad News About the Pfizer Vaccine Isn't So Bad

Jul. 26, 2021 at 6:00 a.m. ET on Motley Fool

Is It Too Late to Buy Novavax Stock?

Jul. 26, 2021 at 5:55 a.m. ET on Motley Fool

Is Pfizer Fairly Valued?

Jul. 25, 2021 at 6:45 a.m. ET on TipRanks.com

3 Dividend Stocks to Buy Hand Over Fist If the Market Crashes

Jul. 25, 2021 at 5:55 a.m. ET on Motley Fool

3 Red-Hot Stocks That Are Still Dirt Cheap

Jul. 25, 2021 at 5:52 a.m. ET on Motley Fool

Why Is Novo Nordisk Buying a Rare-Disease Candidate?

Jul. 24, 2021 at 9:31 a.m. ET on Motley Fool

3 Value Stocks to Buy for the Second Half of 2021

Jul. 24, 2021 at 6:04 a.m. ET on Motley Fool

This News May Hand the Vaccine Market Over to Pfizer and Moderna

Jul. 24, 2021 at 6:00 a.m. ET on Motley Fool

Why Moderna Stock Surged to a New All-Time High Today

Jul. 23, 2021 at 6:58 p.m. ET on Motley Fool

No Headlines Available

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Name	Chg %	Market Cap
Johnson & Johnson	0.46%	$452.6B
Eli Lilly & Co.	0.15%	$233.24B
Abbott Laboratories	0.24%	$212.37B
Novartis AG	0.52%	CHF185.74B
Merck & Co. Inc.	0.79%	$195.58B
AstraZeneca PLC ADR	-0.04%	$177.55B
AstraZeneca PLC	0.00%	£128.45B
Bristol Myers Squibb Co.	-0.30%	$151.21B
Amgen Inc.	-0.16%	$140.81B
Moderna Inc.	-2.19%	$134.86B

Competitor Data Provided By